Account
Karma Capital appoints Pitchfork Partners as communication partner
Mumbai: Portfolio management firm Karma Capital has appointed Pitchfork Partners as strategic communication counsel for outreach for external stakeholders.
The consultancy will spearhead communication for Karma Capital to increase awareness and strengthen the brand narrative, said the statement.
“We look forward to working with Pitchfork Partners as they bring the required expertise and a very strong team to the table,” said Karma Capital co-founder and co-CIO Rushabh Sheth. “With this partnership, we will be able to focus on our core expertise of generating superior long-term returns for investors and depend on Pitchfork for communicating with all our stakeholders.”
“The firm has developed a significant standing in the PMS space and charted comprehensive plans to advance their business. As its communication partner, we will help their brand story scale new heights,” said Pitchfork Partners co-founder Jaideep Shergill.
Karma Capital is an independent, listed equities investment management company that offers portfolio management services (PMS) to domestic and offshore investors across the spectrum of ultra-high net worth individuals, family offices, endowments, pensions, sovereign wealth funds and other large institutional investors.
“Pitchfork understands our business well. As we continue to build the domestic business and renew the focus on our offshore business so that we can become one of the top 10 PMS and alternate investment funds firms in terms of assets under management in India, we value the counsel of partners like Pitchfork,” stated Karma Capital co-head of business development Yogesh Thakkar.
MUMBAI: BigTrunk Communications, an integrated digital marketing agency known for driving brand transformations across industries, has been awarded the digital marketing mandate for Soframycin, one of India’s most trusted antiseptic cream brands from the EncubeEthicals portfolio. With this collaboration, Soframycin makes its debut into the digital space, aiming to amplify its presence across India through compelling social media narratives and data-led campaigns. BigTrunk will lead the brand’s digital strategy and execution, with a focus on connecting Soframycin’s legacy of trust with today’s health-conscious and digitally engaged audience.
Soframycin has been a household name for generations, widely recognized for its efficacy in treating cuts, burns, and wounds. Backed by the scientific rigor and pharmaceutical expertise of EncubeEthicals, a pharmaceutical powerhouse since 1998, the brand benefits from the expertise of over 1,400 professionals, including more than 200 R&D specialists and a robust team of quality experts. With a presence in over 50 countries, Encube’s commitment to excellence in topical formulations adds deep credibility to Soframycin’s legacy. Now, as the brand enters the digital space, BigTrunk Communications will lead the charge in reimagining Soframycin’s story—creating modern, relatable digital experiences that stay true to its heritage.
“As we take Soframycin into its next chapter of growth, embracing digital media is not just a strategy but a necessity. We wanted a partner who could translate our scientific credibility into engaging, relatable content for today’s audience,” said Soframycin vice president – marketing, Ajay Rawal. “BigTrunk’s deep understanding of healthcare communications and digital behavior makes them the ideal partner to build meaningful narratives around wound care, trust, and wellbeing.”
“Soframycin is more than a product—it’s a legacy deeply rooted in care and science,” added BigTrunk Communications founder & managing director Bharat Subramaniam. “We’re excited to take on this responsibility of guiding a heritage brand into the digital world. Our focus will be on creating contextual storytelling and purpose-driven campaigns that bring Soframycin closer to Indian families, both old and new.”
